$2.61 Billion is the total value of TUDOR INVESTMENT CORP ET AL's 1143 reported holdings in Q2 2014. The portfolio turnover from Q1 2014 to Q2 2014 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
PGNX | Progenics Pharmaceuticals Inc. | $10,095,000 | +5.4% | 2,342,388 | 0.0% | 0.39% | -4.7% | |
QCOR | Questcor Pharmaceuticals Inc.put | $3,237,000 | +42.4% | 35,000 | 0.0% | 0.12% | +29.2% | |
IPXL | Impax Labrotories Inc. | $540,000 | +13.4% | 18,000 | 0.0% | 0.02% | +5.0% | |
KALU | Kaiser Aluminum Corp | $415,000 | +2.0% | 5,700 | 0.0% | 0.02% | -5.9% | |
VAC | Marriott Vacations Worldwide Corporation | $346,000 | +4.8% | 5,900 | 0.0% | 0.01% | -7.1% | |
NVR | NVR Inc | $345,000 | +0.3% | 300 | 0.0% | 0.01% | -13.3% | |
FXI | iShares China Large-Cap ETFput | $278,000 | +3.7% | 7,500 | 0.0% | 0.01% | 0.0% | |
AVEO | Aveo Pharmaceuticals Inc | $195,000 | +21.9% | 106,701 | 0.0% | 0.01% | 0.0% | |
MHGC | Morgans Hotel Group Co | $153,000 | -1.3% | 19,262 | 0.0% | 0.01% | -14.3% | |
GTXI | GTx Inc | $61,000 | -10.3% | 44,285 | 0.0% | 0.00% | -33.3% | |
LXRX | Lexicon Pharmaceuticals Inc | $40,000 | -7.0% | 24,640 | 0.0% | 0.00% | 0.0% | |
IMUC | Immunocellular Therapeutics | $45,000 | -8.2% | 40,569 | 0.0% | 0.00% | 0.0% | |
ARQL | Arqule Inc | $24,000 | -22.6% | 15,323 | 0.0% | 0.00% | 0.0% | |
AMSC | American Superconductor Corporation | $29,000 | 0.0% | 17,922 | 0.0% | 0.00% | 0.0% | |
TWGP | Tower Group International Ltd | $25,000 | -34.2% | 14,073 | 0.0% | 0.00% | -50.0% | |
ENZN | Enzon Pharmaceuticals Inc | $38,000 | +2.7% | 36,398 | 0.0% | 0.00% | -50.0% | |
NAVB | Navidea Biopharmaceuticals Inc | $34,000 | -19.0% | 22,904 | 0.0% | 0.00% | -50.0% | |
GNKOQ | Genco Shipping & Trading Ltd^07/14 | $22,000 | -46.3% | 23,493 | 0.0% | 0.00% | -50.0% | |
GEVO | Gevo Inc | $32,000 | -27.3% | 37,304 | 0.0% | 0.00% | -50.0% | |
KIORQ | Kior Inc - Cl A | $4,000 | -33.3% | 10,693 | 0.0% | 0.00% | – | |
LLEN | L&l Energy Inc | $6,000 | -71.4% | 16,475 | 0.0% | 0.00% | -100.0% | |
BGMD | Bg Medicine Inc | $12,000 | -47.8% | 11,879 | 0.0% | 0.00% | -100.0% | |
VGZ | Vista Gold Corporation | $6,000 | 0.0% | 11,100 | 0.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-08-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Cme Group Inc - US | 45 | Q2 2024 | 1.4% |
Nike Inc - US Class B | 41 | Q2 2024 | 0.4% |
Lam Research Corp - US | 41 | Q2 2024 | 0.3% |
Nvidia Corp - US | 40 | Q2 2024 | 0.9% |
Micron Technology Inc - US | 40 | Q2 2024 | 0.4% |
Activision Blizzard Inc - US | 39 | Q3 2023 | 2.8% |
Jd.Com Inc - US ADR | 39 | Q2 2024 | 0.9% |
Target Corp - US | 39 | Q2 2024 | 0.7% |
Meta Platforms Inc - US | 38 | Q2 2024 | 6.7% |
Apple Inc - US | 38 | Q2 2024 | 4.7% |
View TUDOR INVESTMENT CORP ET AL's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
GAIN Capital Holdings, Inc.Sold out | February 14, 2014 | 0 | 0.0% |
PROGENICS PHARMACEUTICALS INC | February 14, 2014 | 2,342,388 | 3.8% |
Uni-Pixel | November 12, 2009 | 4,929,111 | 9.5% |
BigString CORP | February 09, 2009 | 995,712 | 1.9% |
ENHERENT CORP | February 09, 2009 | 6,593,336 | 12.6% |
FiberTower CORP | February 09, 2009 | 876,958 | 0.6% |
International Fight League, Inc. | February 09, 2009 | 955,886 | 1.2% |
KIT digital, Inc. | February 09, 2009 | 1,182,527 | 1.0% |
TERRESTAR CORP | February 09, 2009 | 42,798 | 0.0% |
ULURU INC. | February 09, 2009 | 628,873 | 1.0% |
View TUDOR INVESTMENT CORP ET AL's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-08-14 |
13F-HR | 2024-05-15 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-15 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
View TUDOR INVESTMENT CORP ET AL's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.